The effects of NMDA receptor antagonist MK-801 on lipid peroxidation during focal cerebral ischemia in rats

被引:21
|
作者
Serteser, M [1 ]
Ozben, T
Gumuslu, S
Balkan, S
Balkan, E
机构
[1] Afyon Kocatepe Univ, Sch Med, Dept Biochem, Afyon, Turkey
[2] Akdeniz Univ, Sch Med, Dept Biochem, Antalya, Turkey
[3] Akdeniz Univ, Sch Med, Dept Neurol, Antalya, Turkey
[4] Akdeniz Univ, Sch Med, Dept Otorhinolaryngol, Antalya, Turkey
关键词
conjugated dienes; focal ischemia; malondialdehyde; MK-801;
D O I
10.1016/S0278-5846(01)00332-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The effect of MK-801 on ischemic neuronal damage was studied in a rat model of permanent focal cerebral ischemia in terms of ipsilateral and contralateral cortical and cerebellar tissue lipid peroxides. Forty-five male Swiss Albino rats were assigned into one of four groups: sham operated as controls, subjected to right middle cerebral artery occlusion (MCAO) or injection of MK-801 (0.5 mg/kg ip) either 30 min before or just after right MCAO. Changes in lipid peroxides were expressed as nmol malondialdehyde (MDA) and conjugated diene (CD)/mg protein. MDA values after 60 min of ischemia relative to contralateral cortex and CD levels in 0, 10 and 60 min after ischemia were found to be higher in ipsilateral cortex than those in contralateral cortex. On the other hand, contralateral cerebellar MDA levels in 0 and 60 min of ischemia and CD levels in 0, 10 and 60 min after ischemia were found to be higher than those in ipsilateral cerebellum. Pharmacological inhibition of glutamate receptor by MK-801 before or just after permanent MCAO decreased significantly the MDA and CD levels in both cortex and cerebellum. Although no significant differences found in MDA values between rats pre- and posttreated with MK-801, CD levels in posttreated group seemed significantly lower than those in pretreated group. On the whole, these results suggest that MDA and CD represent early biochemical marker of lipid peroxidation in ischemic tissues, reflecting the radical-mediated tissue damage. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:871 / 877
页数:7
相关论文
共 50 条
  • [41] Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow
    Robertson, SC
    Wetjen, NM
    Beer, BJ
    Loftus, CM
    JOURNAL OF NEUROSURGERY, 1997, 87 (06) : 927 - 933
  • [42] ANXIOLYTIC-LIKE EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST MK-801
    XIE, ZC
    COMMISSARIS, RL
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 43 (02) : 471 - 477
  • [43] Effects of NMDA antagonist, MK-801 on spatial exploratory behavior in the rat
    Sekiguchi, R
    JAPANESE JOURNAL OF PSYCHOLOGY, 1997, 68 (02): : 88 - 94
  • [44] Effects of the NMDA antagonist MK-801 on radial maze performance in histidine-deficient rats
    Nishiga, M
    Sugimoto, Y
    Taga, C
    Fujii, Y
    Kamei, C
    LIFE SCIENCES, 2002, 70 (18) : 2199 - 2208
  • [45] EFFECTS OF MK-801 ON CEREBRAL REGIONAL O2 CONSUMPTION IN FOCAL CEREBRAL-ISCHEMIA
    CHI, OZ
    ANWAR, M
    SINHA, AK
    WEISS, HR
    FASEB JOURNAL, 1991, 5 (05): : A1112 - A1112
  • [46] Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801
    Pitsikas, Nikolaos
    Zisopoulou, Styliani
    Sakellaridis, Nikolaos
    JOURNAL OF NEUROSCIENCE RESEARCH, 2006, 84 (02) : 299 - 305
  • [47] POSSIBLE ABUSE POTENTIAL OF THE NMDA ANTAGONIST MK-801
    CORBETT, D
    BEHAVIOURAL BRAIN RESEARCH, 1989, 34 (03) : 239 - 246
  • [48] EFFECTS OF THE NMDA RECEPTOR ANTAGONIST MK-801 AGAINST AMYGDALOID-KINDLED SEIZURES IN THE RAT
    YOUNG, NA
    LEWIS, SJ
    VAJDA, FJE
    BEART, PM
    EXPERIMENTAL NEUROLOGY, 1989, 103 (02) : 199 - 202
  • [49] INHIBITION OF MORPHINE-TOLERANCE AND DEPENDENCE BY THE NMDA RECEPTOR ANTAGONIST MK-801
    TRUJILLO, KA
    AKIL, H
    SCIENCE, 1991, 251 (4989) : 85 - 87
  • [50] Methylphenidate (MPH) and MK-801, an NMDA receptor antagonist: Shared biological properties
    Husson, I
    Mesples, B
    Medja, F
    Leroux, P
    Kosofsky, BE
    Gressens, P
    PEDIATRIC RESEARCH, 2004, 55 (04) : 412A - 412A